Speaker: Dr Mary Mazur-Melnyk Seminar will be conducted online via Zoom @ 5:30 pm EDT Abstract The presentation will provide an overview of the regulatory process and associated requirements during all phases of clinical study drug development conducted both in the US and Canada with the ultimate focus of market approval. The main objective is to […]
Speaker: Dr Robin Walker Seminar will be conducted online via Zoom @ 5:30 pm EDT and 3:30 MDT Abstract Non-clinical safety assessment is an essential and important component of the drug development process. It is highly regulated with the main sets of compliance requirements being Good Laboratory Practice (GLP) regulations (OECD and individual country) that stipulate how the […]
Speaker: Dr John Tobin, Acanthus Research Inc. Seminar will be conducted online via Zoom @ 5:30 pm EDT and 3:30 MDT Abstract An overview of the Drug Development Process will be presented based on observations from the perspective of a formulation scientist with 30+ years industry experience. The significance of interdisciplinary collaboration through out all stages of the process (from pre-clinical to post-commercialization) will be discussed. Speaker: Dr. […]
